My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avidity Biosciences, Inc. - Common Stock (NQ:RNA)

41.41 -1.80 (-4.15%)
Streaming Delayed Price Updated: 11:41 AM EDT, Sep 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 417,949
Open 43.32
Bid (Size) 41.41 (3)
Ask (Size) 41.49 (1)
Prev. Close 43.21
Today's Range 41.31 - 43.32
52wk Range 21.51 - 56.00
Shares Outstanding 54,462,518
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Looking Into Avidity Biosciences's Recent Short Interest
 
Via Benzinga
Crude Oil Rises 1%; Manufacturing Activity in New York Falls In September
 
Via Benzinga

Performance

YTD
+32.8%
+32.8%
1 Month
-8.5%
-8.5%
3 Month
+38.5%
+38.5%
6 Month
+29.2%
+29.2%
1 Year
-5.9%
-5.9%

More News

Read More
IBEX, Tesla, IonQ, Warner Bros. Discovery And Other Big Stocks Moving Higher On Friday
Via Benzinga
Nasdaq Jumps Over 150 Points; Kroger Earnings Top Estimates
Via Benzinga
Thursday's session: gap up and gap down stocks
Via Chartmill
Why Is Avidity Biosciences Stock Down 20% Pre-market Today?
Via Stocktwits
Novartis Reportedly Eyeing To Acquire Avidity Biosciences: But Retail Expects Management To Sell Only At Significant Premium
Via Stocktwits
Why Oxford Industries Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Discover the top movers in Thursday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Lovesac, Avidity Biosciences, Veritone And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Wednesday's after hours session: top gainers and losers
Via Chartmill
Avidity Drug Shows Yearlong Gains In Duchenne Muscular Dystrophy Trial
Via Benzinga
Deep Dive Into Avidity Biosciences Stock: Analyst Perspectives (8 Ratings)
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Avidity Biosciences (NASDAQ:RNA) Exhibits High-Quality Technical Breakout Setup
Via Chartmill
Avidity (RNA) Q2 Revenue Jumps 88%
Via The Motley Fool
Avidity Biosciences Rockets As Novartis Reportedly Mulls A Takeover Deal
Via Investor's Business Daily
Veritex Holdings, Sequans Communications, Canaan And Other Big Stocks Moving Higher On Monday
Via Benzinga
Expert Outlook: Avidity Biosciences Through The Eyes Of 11 Analysts
Via Benzinga
The Analyst Verdict: Avidity Biosciences In The Eyes Of 12 Experts
Via Benzinga
Avidity Biosciences Touts Encouraging Functional Gains And Biomarker Reductions In Rare Muscular Weakness Disease Trial
Via Benzinga
12 Analysts Assess Avidity Biosciences: What You Need To Know
Via Benzinga
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost
Via Investor's Business Daily
Topics Government

Frequently Asked Questions

Is Avidity Biosciences, Inc. - Common Stock publicly traded?
Yes, Avidity Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Avidity Biosciences, Inc. - Common Stock trade on?
Avidity Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Avidity Biosciences, Inc. - Common Stock?
The ticker symbol for Avidity Biosciences, Inc. - Common Stock is RNA on the Nasdaq Stock Market
What is the current price of Avidity Biosciences, Inc. - Common Stock?
The current price of Avidity Biosciences, Inc. - Common Stock is 41.41
When was Avidity Biosciences, Inc. - Common Stock last traded?
The last trade of Avidity Biosciences, Inc. - Common Stock was at 09/25/25 11:41 AM ET
What is the market capitalization of Avidity Biosciences, Inc. - Common Stock?
The market capitalization of Avidity Biosciences, Inc. - Common Stock is 2.26B
How many shares of Avidity Biosciences, Inc. - Common Stock are outstanding?
Avidity Biosciences, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.